Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 February 2023 | Story Rulanzen Martin | Photo Anja Aucamp
Samson Diamond, Jeanne-Louise Moolman, Prof Anmari van der Westhuizen-Joubert, and Sharon de Kock with the QoP instruments created by luthier Brian Lisus to honour SA’s Nobel peace laureates.

Hope, the viola; Freedom, the first violin; Peace, the second violin; and Reconciliation, the cello, collectively known as the Quartet of Peace (QoP), have found their home at the UFS. The Odeion String Quartet (OSQ) has been made the custodians of this world-famous quartet created by Brian Lisus. The instruments were created by Lisus in 2010 to commemorate the four Nobel peace laureates of South Africa, namely Albert Luthuli, Nelson Mandela, FW de Klerk, and Desmond Tutu. In March 2022, Lisus presented a lecture in the Odeion Theatre to officially present these instruments to the UFS.

Many new performing opportunities 

“The trustees found that justice will be done by making the Odeion String Quartet the new custodians, since they are the only quartet-in-residence at a South African university,” says Prof Anmari van der Westhuizen-Joubert, cellist and Head of the OSQ.

As the custodians of the QoP, it brought many new performing opportunities, both nationally and internationally. “It can also be used in presentations of lectures on all subjects and not only of a political nature. In this way, string quartet music reaches more people than just those who go to concert halls,” Prof Van der Westhuizen-Joubert says. The OSQ consists of Prof Van der Westhuizen-Joubert (cellist), Samson Diamond (violinist and leader of the string quartet), Sharon de Kock (violinist), and Jeanne-Louise Moolman (violinist).

Unique part of UFS identity

The uniqueness of the QoP instruments will be an important element of the OSQ, the Odeion School of Music, the Faculty of the Humanities, as well as the entire UFS community. “One of the plans is to raise money to enable students to come and study with the Odeion String Quartet members at the UFS,” Prof Van der Westhuizen-Joubert says. Another historic moment with these instruments took place in October 2022, when the instruments took centre stage at a concert hosted by Prof Francis Petersen, UFS Rector and Vice-Chancellor, at Constitution Hill in Johannesburg. At this event, the QoP instruments were introduced to the public, important stakeholders, and to guests of the UFS. Other plans include trips to international festivals such as the Ojai Music Festival in the USA in 2023 and the String Quartet Biennale in Amsterdam in 2024.

*This article  first appeared in the Bult Magazine.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept